SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-09-016044
Filing Date
2009-03-10
Accepted
2009-03-10 15:26:07
Documents
8
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a09-1369_110k.htm 10-K 1625943
2 EX-10.68 a09-1369_1ex10d68.htm EX-10.68 23622
3 EX-21.1 a09-1369_1ex21d1.htm EX-21.1 4298
4 EX-23.1 a09-1369_1ex23d1.htm EX-23.1 3143
5 EX-31.1 a09-1369_1ex31d1.htm EX-31.1 11521
6 EX-31.2 a09-1369_1ex31d2.htm EX-31.2 11524
7 EX-32.1 a09-1369_1ex32d1.htm EX-32.1 9336
8 GRAPHIC g13691ba05i001.gif GRAPHIC 9305
  Complete submission text file 0001104659-09-016044.txt   1703867
Mailing Address ONE SW COLUMBIA SUITE 1105 PORTLAND OR 97258
Business Address ONE SW COLUMBIA STE 1105 PORTLAND OR 97258 5032270554
AVI BIOPHARMA INC (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-14895 | Film No.: 09669282
SIC: 2834 Pharmaceutical Preparations